Table 1.
Characteristic | Patients, No. (%)a |
---|---|
Age, median (IQR), y | 34.0 (26.5–49.4) |
Sex | |
Male | 77 (69.4) |
Female | 34 (30.6) |
BMI, median (IQR), kg/m2 | 20.4 (18.5–22.6) |
Family status | |
Single | 42 (38.5) |
Married | 54 (49.5) |
Divorced/separated | 8 (7.3) |
Widowed | 5 (4.6) |
Employment status | |
Employed | 16 (14.5) |
Unemployed | 81 (73.6) |
Pensioner | 9 (8.2) |
Student | 4 (3.6) |
History of incarceration | 34 (30.6) |
Tobacco use | 48 (43.6) |
Alcohol use | |
Never | 63 (59.4) |
Moderate | 34 (32.1) |
Excessive (>5 drinks/d) | 9 (8.5) |
History of intravenous drug use | 3 (3.2) |
HCV antibody positive | 23 (20.7) |
HIV disease | 3 (2.9) |
Other comorbid conditions | |
Cardiovascular disease | 3 (2.7) |
Diabetes mellitus | 9 (8.1) |
Renal disease | 1 (0.9) |
Thyroid disease | 8 (7.2) |
HBV core antibody positive | 4 (3.6) |
History of malignancy | 2 (1.8) |
Psychiatric disease | 9 (8.1) |
Known MDR tuberculosis contact | 26 (23.6) |
Tuberculosis location | |
Pulmonary | 98 (88.3) |
Pulmonary and extrapulmonary | 8 (7.2) |
Extrapulmonaryb | 5 (4.5) |
XDR tuberculosis case type | |
Newly diagnosed | 59 (53.2) |
Retreatment | 52 (46.8) |
Previous treatment | |
First-line drugs only | 29 (55.8) |
First- and second-line drugs | 23 (44.2) |
Abbreviations: BMI, body mass index; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; IQR, interquartile range; MDR, multidrug-resistant; XDR, extensively drug-resistant.
aData represent no. (%) of patients unless otherwise specified.
bExtrapulmonary locations were pleural in 4 patients and urogenital in 1.